Hieu Lam
Impact in
-
- Lung Cancer Treatments and Mutations
- Advanced Breast Cancer Therapies
- Oncology top 5%
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
Papers in
- Oncology 5
- Lung Cancer Research Studies 3
-
- Cancer therapeutics and mechanisms 3
- Genomics and Chromatin Dynamics 2
- Kruppel-like factors research 1
- Co-authors
- Rose Ann Ferre (1 shared paper)Nathan V. Lee (1 shared paper)Asako Nagata (1 shared paper)Meirong Xu (1 shared paper)Brion William Murray (1 shared paper)Xiu Yu (1 shared paper)You-Ai He (1 shared paper)James E. Solowiej (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (3 papers)Cancer Cell (1 paper)Experimental Cell Research (1 paper)Journal of Biotechnology (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesHong KongAustralia
In The Last Decade
Hieu Lam
11 papers receiving 1.6k citations
Hieu Lam's Hit Papers
Peers
Comparison fields: 5 of 74
- Pulmonary and Respiratory Medicine 926
- Oncology 712
- Genetics 110
- Molecular Biology 709
- Cancer Research 133
Countries citing papers authored by Hieu Lam
This map shows the geographic impact of Hieu Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hieu Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hieu Lam more than expected).
Fields of papers citing papers by Hieu Lam
This network shows the impact of papers produced by Hieu Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hieu Lam. The network helps show where Hieu Lam may publish in the future.
Co-authors
The 25 scholars most cited alongside Hieu Lam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Discovery of (10 R )-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- 2H -8,4-(metheno)pyrazolo[4,3- h ][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations Hit paper breakdown → | 2014 | 493 |
| 2 | 2015 | 396 | |
| 3 | 2016 | 359 | |
| 4 | 2014 | 105 | |
| 5 | 1994 | 80 | |
| 6 | 2009 | 51 | |
| 7 | 2023 | 48 | |
| 8 | 2012 | 41 | |
| 9 | 1998 | 35 | |
| 10 | 1998 | 11 | |
| 11 | First-in-class KAT6A/KAT6B inhibitor CTx-648 (PF-9363) demonstrates potent anti-tumor activity in ER plus breast cancer with KAT6A dysregulation. | 2021 | 1 |
About Hieu Lam
Hieu Lam is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Virology and Genetics, having authored 11 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer therapeutics and mechanisms (3 papers), Genomics and Chromatin Dynamics (2 papers), Mast cells and histamine (1 paper), Cancer Genomics and Diagnostics (1 paper), Kruppel-like factors research (1 paper) and Biomedical and Engineering Education (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (926 citations), Oncology (712 citations), Genetics (110 citations), Molecular Biology (709 citations) and Cancer Research (133 citations). Hieu Lam has collaborated with scholars based in United States, Hong Kong and Australia. Frequent co-authors include Rose Ann Ferre, Nathan V. Lee, Asako Nagata, Meirong Xu, Brion William Murray, Xiu Yu, You-Ai He, James E. Solowiej, Wade C. Diehl and Wenyue Hu. Their work appears in journals such as Journal of Medicinal Chemistry, Cancer Cell, Experimental Cell Research, Journal of Biotechnology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.